Echo Therapeutics Fundamentals

ECTE -  USA Stock  

USD 0.0002  0.00  0.00%

Echo Therapeutics fundamentals help investors to digest information that contributes to Echo Therapeutics' financial success or failures. It also enables traders to predict the movement of Echo Therapeutics OTC Stock. This fundamental analysis module provides a way for investors to measures Echo Therapeutics' intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Echo Therapeutics otc stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Echo Therapeutics Fundamentals 

 
Refresh

Echo Therapeutics Market Capitalization Analysis

Echo Therapeutics' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
More About Market Capitalization | All Equity Analysis

Current Echo Therapeutics Market Capitalization

    
  48.02 K  
Most of Echo Therapeutics' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Echo Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Compare to competition

Based on the recorded statements, the market capitalization of Echo Therapeutics is about 48.02 K. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The market capitalization for all United States stocks is 100.0% higher than that of the company.

Echo Therapeutics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Echo Therapeutics's current stock value. Our valuation model uses many indicators to compare Echo Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Echo Therapeutics competition to find correlations between indicators driving Echo Therapeutics's intrinsic value. More Info.
Echo Therapeutics is rated below average in return on equity category among related companies. It is rated below average in total asset category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Echo Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Echo Therapeutics' OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Echo Therapeutics' earnings, one of the primary drivers of an investment's value.

Echo Therapeutics Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Echo Therapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Echo Therapeutics could also be used in its relative valuation, which is a method of valuing Echo Therapeutics by comparing valuation metrics of similar companies.
Echo Therapeutics is currently under evaluation in current valuation category among related companies.

Echo Therapeutics Fundamentals

About Echo Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Echo Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Echo Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Echo Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. The company was founded in 1989 and is headquartered in Iselin, New Jersey. Echo Therapeutics operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 19 people.

Echo Therapeutics Investors Sentiment

The influence of Echo Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Echo Therapeutics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - ECTE

Echo Therapeutics Investor Sentiment

Most of Macroaxis users are currently bullish on Echo Therapeutics. What is your opinion about investing in Echo Therapeutics? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Echo Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Echo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Echo Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Echo Therapeutics Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Echo Therapeutics and Abbott Laboratories. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Investing Opportunities. Note that the Echo Therapeutics information on this page should be used as a complementary analysis to other Echo Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Echo Therapeutics OTC Stock analysis

When running Echo Therapeutics price analysis, check to measure Echo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Echo Therapeutics is operating at the current time. Most of Echo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Echo Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Echo Therapeutics' price. Additionally, you may evaluate how the addition of Echo Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Is Echo Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Echo Therapeutics. If investors know Echo Therapeutics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Echo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Echo Therapeutics is measured differently than its book value, which is the value of Echo Therapeutics that is recorded on the company's balance sheet. Investors also form their own opinion of Echo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Echo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Echo Therapeutics' market value can be influenced by many factors that don't directly affect Echo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Echo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Echo Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Echo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.